Accelerator to End TB in India Broad Agency Announcement (BAA)
India USAID-New Delhi · Agency for International Development
At a glance
Accelerator to End TB in India Broad Agency Announcement (BAA) is a closed federal other opportunity from the India USAID-New Delhi (Agency for International Development). The application deadline was May 12, 2019. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing or matching is required. It is funded under Assistance Listing 98.001 (USAID Foreign Assistance for Programs Overseas).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Apr 11, 2019Posted
- May 12, 2019Application deadline
- Posted
- Apr 11, 2019
- Close date
- May 12, 2019
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- Not specified
- Original deadline (extended)
- May 10, 2019
- Expected awards
- 4
- Cost sharing
- Required
- Funding instrument
- Other
- Opportunity category
- Other
Who can apply
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The United States Agency forInternational Development (USAID) is issuing this Broad Agency Announcement(BAA) to seek participants to co-create, co-design, co-invest, and collaborateon research and development interventions to rapidly demonstrate and rigorouslytest person-centered, high-impact and novel solutions that can accelerate theGovernment of India’s (GOI) efforts to eliminate Tuberculosis (TB) by2025. USAID invites organizations andcompanies to submit an Expression of Interest, as provided below.
Achieving the ambitious goal of ending TB by 2025 necessitates a paradigm shift inapproach and strategy. Partnering withthe GOI, USAID is calling for groundbreaking approaches to accelerate areduction in TB, with a special focus on multidrug-resistant/rifampicin resistant TBMDR/RR-TB. USAID will invest inout-of-the-box, but achievable solutions that leapfrog conventional approachesto ensure a person-centered approach to prevent, diagnose and treat TB. USAID is particularly interested in investingin and supporting approaches that strengthen the enabling environment, enhanceservice delivery platforms and integrate the latest behavior change approacheswith scientific and/or technological advances for maximum impact. Critical to the sustained success of thehigh-impact solutions is a defined understanding and pathway of how to ensurethat TB services are accessible for all, including priority and vulnerablepopulations, and fostering diverse local partnerships that can help catalyzesuccessful implementation.
Theintent of the BAA is to allow co-creation and co-design to the maximum extentto create high quality, effective partnerships with great efficiency in timeand resources. USAID will inviteselected for-profit and non-profit, faith-based, public and privateorganizations, as detailed below, to co-create solutions to the Problem andChallenge Statements stated in this BAA, including those organizations thathave ideas, expertise, resources, and/or funding to add to potential solutions.
Co-Investing: USAID wants to aligngoals with the partners under this BAA, to facilitate shared responsibility,shared risk, and shared resourcing. Shared resourcing requires that cash and other resources, both tangibleand intangible, such as in-kind contributions, expertise, intellectualproperty, brand value, high-value coordination, and access to key people,places, and information, are directed towards reaching the solution to theProblem/Challenge. Co-investing does not require equal shared resources (suchas 1:1 leverage), but rather resource contributions that are appropriate to thespecific project’s objectives, considering the comparative advantages broughtby the participation of each party.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
- Accelerator to End TB in India BAAFull Announcement · BAA - TB Announcement.pdfPDF · 303 KB
- Amendment No. 4Other Supporting Documents · Amend No. 4 - BAA.pdfPDF · 166 KB
- BAA-ROAA-ENDTB-2019, AMENDMENT NO. 5Other Supporting Documents · Amendment 05 to BAA-ROAA-ENDTB-2019.pdfPDF · 64 KB
- Webinar PresentationOther Supporting Documents · Presentation of the BAA Webinar.pdfPDF · 332 KB
Assistance Listing
What is an ALN?Reported obligations under ALN 98.001
Historical data · not a predictionAgency contact (as published)
Monika Gulati A and A Specialist
indiarco@usaid.gov
911124198569
Quick answers
Who is eligible to apply for “Accelerator to End TB in India Broad Agency Announcement (BAA)”?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How do I apply for “Accelerator to End TB in India Broad Agency Announcement (BAA)”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity BAA-ROAA-ENDTB-2019), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Title X Family Planning Services Grants
Office of the Assistant Secretary for Health- Award range
- $200K – $22M
- Closes
- Jan 11, 2027
- Who can apply
- State governments, County governments, City or township governments and 10 more
Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Mar 1, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
RNomics Technology Enhancement Centers
National Institutes of Health- Award range
- Up to $2M
- Est. close
- Feb 1, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jun 10, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Department of Defense HIV/AIDS Prevention Program
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Sep 18, 2027
- Who can apply
- Unrestricted (any entity type)
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Sep 30, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more